NovaBay Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
NovaBay Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 4.89M shares, a 25.2% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 4.89M -1.64M -25.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 1.35M -2.87M -68% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 32M +30M +1474% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 321K -1.71M -84.2% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 6.53M -58.5M -90% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 4.21M -49.3M -92.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 2.04M -49.4M -96% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 2.04M +670K +49.1% Dec 31, 2022 10-K 2024-03-26
Q3 2022 65M +20M +44.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 53.5M +8.9M +19.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 51.4M +9.64M +23.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 1.37M -40.4M -96.7% Dec 31, 2021 10-K 2023-03-31
Q3 2021 44.9M +3.18M +7.62% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 44.6M +9.97M +28.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 41.8M +13.5M +48% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 41.8M +13.8M +49.6% Dec 31, 2020 10-K 2022-03-29
Q3 2020 41.8M +16.6M +65.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 34.6M +13.9M +67.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 28.2M +11.1M +65.2% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 27.9M +10.8M +63.5% Dec 31, 2019 10-K 2021-03-25
Q3 2019 25.2M +8.11M +47.5% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 20.7M +3.64M +21.3% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 17.1M +6K +0.04% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 17.1M +1.7M +11.1% Dec 31, 2018 10-K 2020-03-26
Q3 2018 17.1M +1.73M +11.2% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 17.1M +1.78M +11.6% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 17.1M +1.8M +11.8% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 15.4M +116K +0.76% Dec 31, 2017 10-K 2019-03-29
Q3 2017 15.4M -14.9B Sep 30, 2017 10-Q 2017-11-14
Q2 2017 15.3M +6.15M +67.2% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 15.3M +15.3M Mar 31, 2017 10-Q 2017-05-11
Q4 2016 15.3M +11.8M +338% Dec 31, 2016 10-K 2018-03-21
Q3 2016 14.9B* +14.8B Sep 30, 2016 10-Q 2016-11-10
Q2 2016 9.16M -64.5M -87.6% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 5.08K* -61.1M Mar 31, 2016 10-Q 2016-05-12
Q4 2015 3.49M +1.42M +68.7% Dec 31, 2015 10-K 2017-03-23
Q3 2015 74.6M +23.5M +45.9% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 73.6M +22.9M +45% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 61.1M +10.4M +20.5% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 2.07M -42.6M -95.4% Dec 31, 2014 10-K 2016-03-04
Q3 2014 51.1M +12.5M +32.3% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 50.8M +13.4M +35.9% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 50.7M +13.5M +36.2% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 44.6M +7.71M +20.9% Dec 31, 2013 10-K 2015-03-26
Q3 2013 38.7M +8.9M +29.9% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 37.4M +8.49M +29.4% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 37.2M +8.41M +29.2% Mar 31, 2013 10-Q 2013-05-02
Q4 2012 36.9M +8.33M +29.1% Dec 31, 2012 10-K 2014-03-06
Q3 2012 29.7M +1.42M +4.99% Sep 30, 2012 10-Q 2012-11-01
Q2 2012 28.9M +5.38M +22.9% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 28.8M Mar 31, 2012 10-Q 2012-05-03
Q4 2011 28.6M +5.2M +22.2% Dec 31, 2011 10-K 2013-03-14
Q3 2011 28.3M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 23.5M Jun 30, 2011 10-Q 2011-08-10
Q4 2010 23.4M Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.